intense new band at 520 nm appeared on addition of CNÀ
indicating competitive binding of 4 with CNÀ (Fig. S40).
As the concentration of Fe3+ (0.01 mM) in the human body10 is
B5 times the lethal concentration of CNÀ (41.9 mM), it was
worth checking the behaviour of 4 towards CNÀ in presence of
Fe3+. Addition of 15 equiv of Fe3+ (w.r.t. CNÀ) to a solution of
4 + CNÀ did not affect the color of the solution and the
absorption spectrum as well but further addition of Fe3+ changed
the color of the solution from orange to light yellow and an
absorption band at 520 nm disappeared (Fig. S139b). Therefore,
irrespective of the strong affinity of CNÀ for Fe3+, CNÀ preferred
compound 4 in the presence of even 15 equiv of Fe3+. Moreover,
addition of Mg2+, Cu2+, Zn2+, Co2+ and Ni2+ did not disturb
the color and the absorption spectrum of a solution of 4 + CNÀ.
Scheme 2 Hydrolysis of compound 7 to compound 10.
human serum were recorded. Non-toxicity of compound 4 was
apparent from its higher LC50 value at various cell lines of
human cancer (data not shown here) as well as its similarity to
trimethoprim.7b,12 Under reaction conditions of 4 and CNÀ, 3/4
did not react with cysteine (analogue of GSH).13 Hydrolysis of
compound 7 under basic conditions (usual pH in lower part of
digestive system) provided compound 10 (Scheme 2) indicating the
conversion of CN group to COOH and hence the safe removal of
CNÀ at the end.
Compound 4 did not respond to the biological cations like Fe3+
,
Mg2+, Cu2+, Zn2+, Co2+ and Ni2+. Solutions of compounds
3a and 3b in the same solvent (ethanol–water, 1 : 1) also gave
similar responses to CNÀ (SI, Fig. S41–50).
Therefore, a simple synthesis which could be scaled up to
procure tons of compounds provided compounds 3 and 4 in
which the appreciable acidity of phenolic OH helped in the
detection and binding of CNÀ in presence of other anions and
even 15 equiv of Fe3+ also (biological target of CNÀ). All the
experiments carried out here with compound 4 indicated the
suitability of this compound as an antidote of CNÀ. Study in
living systems is underway.
To check further the working of compound 4 under biological
conditions and the affinity of CNÀ for compound 4 vs. biological
Fe3+ (Fe3+ in porphyrin), human serum (diluted in water) was
used as medium for performing the experiments.
Proteinaceous blood sample (sample I)11 showed absorption
bands at 215 nm and 412 nm (Fig. 2a). Addition of 20 mL of
compound 4 (10 mM) to the above solution of sample I turned the
colorless solution light yellow. The UV-vis spectrum of this
solution exhibited usual absorption bands of compound 4 and a
new band at 520 nm (Fig. 2a). To rule out if the absorption band
at 520 nm is due to the interactions of compound 4 with
some proteins in the blood sample, a non-proteinaceous sample
(sample II)11 of blood serum was prepared. Sample II showed
absorption bands at 227 nm and 271 nm (Fig. 2b). Addition of
20 mL of compound 4 (10 mM) to a solution of sample II turned
the colorless solution light yellow and the UV-vis spectrum of this
solution also exhibited an absorption band at 520 nm (Fig. 2b).
The absorption band at 520 nm seems to be due to the presence of
Financial assistance from CSIR, DST New Delhi is gratefully
acknowledged. MK thanks UGC, New Delhi for SRF.
Notes and references
1 (a) T. D. Jeffery, O. Oluyomi and Q. Roberto, Chem. Soc. Rev., 2010,
39, 3843–3862; (b) J. L. Sessler, P. A. Gale and W.-S. Cho, in Anion
Receptor Chemistry, Royal Society of Chemistry, 2006; (c) P. D. Beer
and P. A. Gale, Angew. Chem., Int. Ed., 2001, 40, 486–516;
(d) E. M. Stanley, in Fundamentals of Environmental Chemistry,
Taylor and Francis Group LLC, 2009, ch. 12, pp. 417–460.
2 Guidelines for Drinking Water Quality, World Health Organisation,
Geneva, 1996.
3 S. I. Baskin and T. G. Brewer, in Medicinal Aspects of Chemical and
Biological Warfare, ed. F. Sidell, E. T. Takafuji and D. R. Frenz,
TMM publications, Washington DC, 1997, ch. 10, pp. 271–286.
4 (a) S. I. Baskin, J. B. Kelly, B. I. Maliner, G. A. Rockwood and
C. K. Zoltani, in Medicinal Aspects of Chemical Warfare, ed.
D. T. Shirley, TMM publications, Washington DC, 2008, ch. 11,
pp. 331–410; (b) J. L. Way, Annu. Rev. Pharmacol. Toxicol., 1984, 24,451.
5 R. Bhattacharya, Indian J. Pharmacol., 2000, 32, 94–101.
6 (a) X. Zhaochao, C. Xiaoqiang, N. K. Ha and Y. Juyoung, Chem. Soc.
Rev., 2010, 39, 127–137; (b) S. Sukdeb, G. Amrita, M. Prasenjit,
M. Sandhya, K. M. Sanjiv, E. Suresh, D. Satyabrata and D. Amitava,
Org. Lett., 2010, 12, 3406–3409; (c) M. R. Ajayakumar and
P. Mukhopadhyay, Org. Lett., 2010, 12, 2646–2649; (d) P. Lihua,
W. Ming, Z. Guannin, Z. Deqing and Z. Daoben, Org. Lett., 2009, 11,
1943–1946; (e) G. C. Dong, H. K. Jong and L. S. Jonathen, J. Am. Chem.
Soc., 2008, 130, 12163–12167; (f) B. Ramachandram, R. L. Joseph and
D. G. Chris, J. Am. Chem. Soc., 2005, 127, 3635–3641.
CNÀ/CO32À/HCO3 in blood itself and this band gets intensified
À
on incremental addition (1 mM to 5 mM) of CNÀ along with color
change of the solution from light yellow to orange to red
(Fig. 2a,b). Addition of CNÀ to a solution of sample I + 4 also
led to an increase in the absorption intensity at 250 nm and
360 nm with concomitant decrease at 228 and 299 nm (Fig. 2a).
Alternatively, addition of compound 4 (10 mM) to a solution of
sample I + CNÀ (10 mM CNÀ) resulted in change in color and the
appearance of an absorption band at 520 nm. Compound 7 was
also isolated from this solution showing the scavenging of CNÀ
from blood serum by compound 4.
It was ensured that treatment of CNÀ containing water sample
and human serum with compound 4 completely removes CNÀ
from the medium. The aqueous part, after extraction of solution
of 4 + CNÀ (10 mM compound 4 and 10 mM NaCN) with ethyl
acetate, did not show color change on addition of compound 4
which otherwise could have been there if CNÀ had been present in
the aqueous part. The aqueous part, left after extraction of
solution of NaCN (in water–ethanol) with ethyl acetate, gave a
color change on addition of compound 4 indicating that CNÀ was
not extracted with ethyl acetate only but it is compound 7 which is
carrying cyanide from the aqueous solution (Fig. S51). The same
observations of complete removal of CNÀ by compound 4 from
7 (a) B. A. Roth, E. A. Falco, G. H. Hitchings and R. M. Bushby, J. Med.
Pharm. Chem., 1962, 5, 1103–1123; (b) W. S. Carl, E. G. Michael and
A. N. Charles, J. Infect. Dis., 1973, 128, S580–S583.
8 N. Wataru and Y. Mitsuru, in Hydrocyanation of Conjugated
Carbonyl Compounds. Organic Reactions, John Wiley & Sons,
2005, pp. 255–476.
9 T. T. Kararli, Biopharm. Drug Dispos., 1995, 16, 351–380.
10 E. M. David and M. M. Carol, in Biochemistry: The Chemical
Reaction of Living Cells, Academic Press, 2001, vol. 2, p. 837.
11 Blood serum of a healthy person was taken with thanks from Dr Ritu,
Govt. Medical College, Amritsar. Prepared by centrifugation.
12 S. R. M. Bushby and G. H. Hitchings, Br. J. Pharmacol.
Chemother., 1968, 33, 72–90.
13 G.-J. Kim, K. Lee, H. Kwon and H.-J. Kim, Org. Lett., 2011, 13,
2799–2801.
c
9124 Chem. Commun., 2011, 47, 9122–9124
This journal is The Royal Society of Chemistry 2011